Highlights of ASH in North America
Save the Date!
Join the world's leading hematology experts at Highlights of ASH in North America, a two-day program offered in multiple locations that highlights the most influential research presented at the latest ASH annual meeting. Registration is now open!
New York, New York | January 10-11, 2025
Seattle, Washington | January 10-11, 2025
Chicago, Illinois | January 17-18, 2025
Washington D.C. | January 31-February 1, 2025
About Highlights of ASH in North America
By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.
Throughout this meeting, you will be able to:
Access a program curated from highlights of the ASH annual meeting which covers the latest and most influential topics in hematology.
Engage in interactive panel discussions with speakers and attend small group lunch sessions with experts in the field.
Choose from several dates and locations to best meet your schedule.
Program Schedule
The program schedule below is identical for all 2025 Highlights of ASH in North America locations. The following information is preliminary and subject to change.
11:00 a.m. | Registration and Exhibits Open (Lunch provided) | |
11:45 p.m. | Welcome and Introductions | |
12:00 p.m. | Inherited Disorders of Coagulation | |
Tyler Buckner, MD, MSc |
Seattle, WA |
|
Patrick Ellsworth, MD University of North Carolina |
New York, NY Chicago, IL |
|
Ayesha Zia, MD University of Texas Southwestern |
Washington, DC | |
12:45 p.m. | Transfusion Medicine | |
Grace Lee, MD Duke University |
Chicago, IL | |
Katerina Pavenski, MD, FRCPC University of Toronto |
Seattle, WA Washington, DC |
|
Michelle Zeller, MD McMaster University |
New York, NY | |
1:30 p.m. | Sickle Cell Disease: Disease-Modifying and Curative Therapies | |
Maureen Okam Achebe, MD, MPH |
New York, NY | |
Cecelia Calhoun, MD, MPHS, MBA Yale University |
Seattle, WA |
|
Rakhi Naik, MD, MHS Johns Hopkins University |
Washington, DC | |
2:15 p.m. | Panel Discussion | |
2:45 p.m. | Coffee Break and Exhibits Open | |
3:00 p.m. |
Acute Lymphoblastic Leukemia |
|
Patrick Burke, MD |
Seattle, WA |
|
Adam Duvall, MD University of Chicago |
Chicago, IL | |
Ryan Mattison, MD University of Wisconsin |
New York, NY Washington, DC |
|
3:45 p.m. |
Myeloma, MGUS, and Plasma Cell Disorders | |
Susan Bal, MD |
New York, NY | |
Doris Hansen, MD |
Chicago, IL | |
Jonathan Kaufman, MD |
Seattle, WA Washington, DC |
|
4:30 p.m. | Acute Myeloid Leukemia | |
Courtney DiNardo, MD Anderson Cancer Center |
Washington, DC | |
Charles Foucar, MD |
Chicago, IL |
|
Catherine Lai, MD, MPH University of Pennsylvania |
Seattle, WA | |
Jerald Radich, MD Fred Hutchinson Cancer Center |
New York, NY | |
5:15 p.m. | Panel Discussion | |
5:45 p.m. | Highlights of ASH Day 1 Program Adjournment | |
6:00 p.m. | Satellite Symposia |
7:00 a.m. | Registration and Exhibits Open (Breakfast provided) |
|
7:45 a.m. | Welcome, Introductions, and Announcements | |
8:00 a.m. |
Intersection of Women’s Health and Hematology |
|
Sarah H. O'Brien, MD, MSc |
New York, NY |
|
Menaka Pai, MD FRCPC McMaster University |
Chicago, IL | |
Bethany Samuelson Bannow, MD Oregon Health and Science University Medicine |
Seattle, WA | |
8:45 a.m. |
Clinical Applications of Health Outcomes Research for Blood Cancers |
|
Pamela Egan, MD |
Washington, DC |
|
Areej El-Jawahri, MD Massachusetts General Hospital |
Seattle, WA | |
Thomas W. LeBlanc, MD, MS, MA Duke University |
New York, NY Chicago, IL |
|
9:30 a.m. |
Consultative Hematology |
|
Cyrus Hsia, MD, FRCPC Western University |
New York, NY | |
Jacquelyn M. Powers, MD Texas Children’s Hospital |
Chicago, IL | |
Joseph Shatzel, MD Oregon Health and Science University Medicine |
Seattle, WA Washington, DC |
|
10:15 a.m. | Panel Discussion | |
10:45 a.m. | Coffee Break and Exhibits Open | |
11:00 a.m. |
Myelodysplastic Syndromes and Clonal Hematopoiesis |
|
Guillermo Garcia-Manero, MD |
Chicago, IL |
|
Morgan Jones, MD, PhD University of Michigan |
New York, NY Washington, DC |
|
Afaf Osman, MD |
Seattle, WA |
|
11:45 a.m. |
Moving the Needle in the Treatment of Myeloproliferative Neoplasms and Chronic Myeloid Leukemia |
|
Chi-Joan How, MD |
Washington, DC |
|
Andrew Kuykendall, MD Moffitt Cancer Center |
Seattle, WA | |
Kristen Pettit, MD University of Michigan |
Chicago, IL |
|
Douglas Tremblay, MD |
New York, NY | |
12:30 p.m. | Panel Discussion | |
1:00 p.m. | Lunch with the Experts (All Speakers and Attendees) |
|
2:15 p.m. | Transplant | |
Ran Reshef, MD, MSc |
New York, NY |
|
Bart L. Scott, MD |
Seattle, WA |
|
Melody Smith, MD, MS Stanford University |
Chicago, IL | |
3:00 p.m. |
Highlights in Aggressive Lymphoma |
|
Paul Barr, MD |
Seattle, WA |
|
Carla Casulo, MD University of Rochester |
Chicago, IL | |
Manali Kamdar, MD |
Washington, DC |
|
Sarah Rutherford, MD Weill Cornell Medicine |
New York, NY | |
3:45 p.m. |
Highlights in Indolent Lymphoma and Chronic Lymphocytic Leukemia |
|
Alexey Danilov, MD, PhD |
Seattle, WA |
|
Jia Ruan, MD, PhD |
New York, NY |
|
Deborah Stephens, DO University of North Carolina |
Chicago, IL |
|
4:30 p.m. | Panel Discussion | |
5:00 p.m. | Closing Remarks and Adjournment |
Acknowledgements
Thank you to our esteemed committee of experts dedicated to advancing the development of this meeting, and our company partners for providing educational grants in support of the 2025 Highlights of ASH in North America
- Jia Ruan, MD, PhD, Chair, Weill Cornell Medicine
- Tyler Buckner, MD, MSc, University of Colorado Denver
- Pamela Egan, MD, Maine Health
- Manali Kamdar, MD, University of Colorado
- Jonathan L. Kaufman, MD, Emory University
- Rakhi Naik, MD, MHS, Johns Hopkins University
- Kristen Pettit, MD, University of Michigan
- Eric Tse, PhD, MBBS, Hong Kong University
- Michelle Zeller, MD, McMaster University